Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TAK and other ETFs, options, and stocks.

About TAK

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. 

CEO
Christophe Weber
CEOChristophe Weber
Employees
47,347
Employees47,347
Headquarters
Osaka, Osaka
HeadquartersOsaka, Osaka
Founded
1781
Founded1781
Employees
47,347
Employees47,347

TAK Key Statistics

Market cap
41.95B
Market cap41.95B
Price-Earnings ratio
25.89
Price-Earnings ratio25.89
Dividend yield
4.58
Dividend yield4.58
Average volume
3.29M
Average volume3.29M
High today
$13.52
High today$13.52
Low today
$13.32
Low today$13.32
Open price
$13.40
Open price$13.40
Volume
3.65M
Volume3.65M
52 Week high
$15.36
52 Week high$15.36
52 Week low
$12.75
52 Week low$12.75

TAK News

Benzinga 9h
Takeda Seeks FDA Approval For Hereditary Angioedema Treatment For Younger Kids

by The FDA has accepted Takeda Pharmaceutical Co Ltd's TAK supplemental marketing application for the potential expanded use of TAKHZYRO (lanadelumab-flyo) for...

Takeda Seeks FDA Approval For Hereditary Angioedema Treatment For Younger Kids

Analyst ratings

53%

of 15 ratings
Buy
53.3%
Hold
40%
Sell
6.7%

TAK Earnings

$0.00
$0.19
$0.37
$0.56
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
per share
Estimated per share
Actual
Available Oct 27, Pre-Market
ActualAvailable Oct 27, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.